These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28844011)

  • 1. The pharmacokinetics of racemic MDPV and its (R) and (S) enantiomers in female and male rats.
    Hambuchen MD; Hendrickson HP; Gunnell MG; McClenahan SJ; Ewing LE; Gibson DM; Berquist MD; Owens SM
    Drug Alcohol Depend; 2017 Oct; 179():347-354. PubMed ID: 28844011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of 3,4-methylenedioxypyrovalerone (MDPV) in male and female Sprague-Dawley rats.
    McClenahan SJ; Hambuchen MD; Simecka CM; Gunnell MG; Berquist MD; Owens SM
    Drug Alcohol Depend; 2019 Feb; 195():140-147. PubMed ID: 30634109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective Effects of Abused "Bath Salt" Constituent 3,4-Methylenedioxypyrovalerone in Mice: Drug Discrimination, Locomotor Activity, and Thermoregulation.
    Gannon BM; Williamson A; Suzuki M; Rice KC; Fantegrossi WE
    J Pharmacol Exp Ther; 2016 Mar; 356(3):615-23. PubMed ID: 26769917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats.
    Berquist MD; Traxler HK; Mahler AM; Baker LE
    Drug Alcohol Depend; 2016 Jul; 164():128-134. PubMed ID: 27181413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reinforcing effects of abused 'bath salts' constituents 3,4-methylenedioxypyrovalerone and α-pyrrolidinopentiophenone and their enantiomers.
    Gannon BM; Rice KC; Collins GT
    Behav Pharmacol; 2017 Oct; 28(7):578-581. PubMed ID: 28570297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective Actions of Methylenedioxypyrovalerone (MDPV) To Inhibit Dopamine and Norepinephrine Transporters and Facilitate Intracranial Self-Stimulation in Rats.
    Kolanos R; Partilla JS; Baumann MH; Hutsell BA; Banks ML; Negus SS; Glennon RA
    ACS Chem Neurosci; 2015 May; 6(5):771-7. PubMed ID: 25688761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the 3,4-methylendioxypyrovalerone/mephedrone combination responsible for enhanced stimulant effects? A rat study with investigation of the effect/concentration relationships.
    Benturquia N; Chevillard L; Poiré C; Roussel O; Cohier C; Declèves X; Laplanche JL; Etheve-Quelquejeu M; Chen H; Mégarbane B
    Psychopharmacology (Berl); 2019 Mar; 236(3):891-901. PubMed ID: 29971461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of MDPV on dopamine transporter regulation in male rats. Comparison with cocaine.
    Lopez-Arnau R; Duart-Castells L; Aster B; Camarasa J; Escubedo E; Pubill D
    Psychopharmacology (Berl); 2019 Mar; 236(3):925-938. PubMed ID: 30284596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography-high resolution mass spectrometry.
    Anizan S; Ellefsen K; Concheiro M; Suzuki M; Rice KC; Baumann MH; Huestis MA
    Anal Chim Acta; 2014 May; 827():54-63. PubMed ID: 24832995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of MDPV and ethanol results in decreased cathinone and increased alcohol levels. Study of such pharmacological interaction.
    López-Arnau R; Buenrostro-Jáuregui M; Muñoz-Villegas P; Rodríguez-Morató J; Ciudad-Roberts A; Duart L; Camarasa J; De la Torre R; Pubill D; Escubedo E
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():19-28. PubMed ID: 28219712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semi-Preparative Separation, Absolute Configuration, Stereochemical Stability and Effects on Human Neuronal Cells of MDPV Enantiomers.
    Almeida AS; Silva B; Silva JP; Pereira JA; Remião F; Fernandes C
    Molecules; 2023 Feb; 28(5):. PubMed ID: 36903367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
    Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
    Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated exposure to 3,4-methylenedioxypyrovalerone and cocaine produces locomotor sensitization with minimal effects on brain monoamines.
    Kohler RJ; Perrine SA; Baker LE
    Neuropharmacology; 2018 May; 134(Pt A):22-27. PubMed ID: 29042316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chiral resolution and absolute configuration of the enantiomers of the psychoactive "designer drug" 3,4-methylenedioxypyrovalerone.
    Suzuki M; Deschamps JR; Jacobson AE; Rice KC
    Chirality; 2015 Apr; 27(4):287-93. PubMed ID: 25727807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological mechanisms underlying the cardiovascular effects of the "bath salt" constituent 3,4-methylenedioxypyrovalerone (MDPV).
    Schindler CW; Thorndike EB; Suzuki M; Rice KC; Baumann MH
    Br J Pharmacol; 2016 Dec; 173(24):3492-3501. PubMed ID: 27714779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linear pharmacokinetics of 3,4-methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effects.
    Anizan S; Concheiro M; Lehner KR; Bukhari MO; Suzuki M; Rice KC; Baumann MH; Huestis MA
    Addict Biol; 2016 Mar; 21(2):339-47. PubMed ID: 25475011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP).
    Glennon RA; Young R
    Brain Res Bull; 2016 Sep; 126(Pt 1):111-126. PubMed ID: 27142261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of a bi-specific vaccine against α-pyrrolidinovalerophenone (α-PVP) and 3,4-methylenedioxypyrovalerone (MDPV) in rats.
    McClenahan SJ; Kormos CM; Gunnell M; Hambuchen MD; Lamb P; Carroll FI; Lewin AH; Peterson EC; Owens SM
    Vaccine; 2020 Jan; 38(2):336-344. PubMed ID: 31629568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and chronic neurobehavioral effects of the designer drug and bath salt constituent 3,4-methylenedioxypyrovalerone in the rat.
    Atehortua-Martinez LA; Masniere C; Campolongo P; Chasseigneaux S; Callebert J; Zwergel C; Mai A; Laplanche JL; Chen H; Etheve-Quelquejeu M; Mégarbane B; Benturquia N
    J Psychopharmacol; 2019 Mar; 33(3):392-405. PubMed ID: 30644332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiral determination of 3,4-methylenedioxypyrovalerone enantiomers in rat serum.
    Hambuchen MD; Hendrickson HP; Owens SM
    Anal Methods; 2017 Jan; 9(4):609-617. PubMed ID: 28286575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.